Denali Therapeutics (DNLI) Other Gross PP&E Adjustments: 2017-2025
Historic Other Gross PP&E Adjustments for Denali Therapeutics (DNLI) over the last 7 years, with Sep 2025 value amounting to -$49.4 million.
- Denali Therapeutics' Other Gross PP&E Adjustments fell 27.82% to -$49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$145.1 million, marking a year-over-year decrease of 90.35%. This contributed to the annual value of $2.0 million for FY2024, which is 83.93% down from last year.
- Latest data reveals that Denali Therapeutics reported Other Gross PP&E Adjustments of -$49.4 million as of Q3 2025, which was down 4.32% from -$47.4 million recorded in Q2 2025.
- In the past 5 years, Denali Therapeutics' Other Gross PP&E Adjustments ranged from a high of $12.3 million in Q4 2023 and a low of -$50.2 million during Q1 2025.
- In the last 3 years, Denali Therapeutics' Other Gross PP&E Adjustments had a median value of -$27.4 million in 2023 and averaged -$27.6 million.
- As far as peak fluctuations go, Denali Therapeutics' Other Gross PP&E Adjustments spiked by 92.71% in 2023, and later crashed by 98.34% in 2025.
- Quarterly analysis of 5 years shows Denali Therapeutics' Other Gross PP&E Adjustments stood at $7.3 million in 2021, then fell by 12.21% to $6.4 million in 2022, then surged by 92.71% to $12.3 million in 2023, then crashed by 83.93% to $2.0 million in 2024, then declined by 27.82% to -$49.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$49.4 million in Q3 2025, compared to -$47.4 million in Q2 2025 and -$50.2 million in Q1 2025.